Product NDC: | 52584-410 |
Proprietary Name: | Digoxin |
Non Proprietary Name: | Digoxin |
Active Ingredient(s): | 250 ug/mL & nbsp; Digoxin |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52584-410 |
Labeler Name: | General Injecatables & Vaccines, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA083391 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100701 |
Package NDC: | 52584-410-31 |
Package Description: | 1 AMPULE in 1 BAG (52584-410-31) > 2 mL in 1 AMPULE |
NDC Code | 52584-410-31 |
Proprietary Name | Digoxin |
Package Description | 1 AMPULE in 1 BAG (52584-410-31) > 2 mL in 1 AMPULE |
Product NDC | 52584-410 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Digoxin |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20100701 |
Marketing Category Name | ANDA |
Labeler Name | General Injecatables & Vaccines, Inc |
Substance Name | DIGOXIN |
Strength Number | 250 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Cardiac Glycoside [EPC],Cardiac Glycosides [Chemical/Ingredient] |